《港股开市》恒指高开457点 赌股航空股弹 复星医药涨15%
新冠疫苗取得突破，美股道指升834点或3%，亚太股市接力上升，港股高开。恒指开市升457点或1.8%，报26,474点；国指高开72点或0.7%，报10,705点；恒生科技指数随纳指倒跌低开179点或2.1%，报8,214.52点。
科技股低开，腾讯(00700.HK)跌2.3%报608元，阿里巴巴(09988.HK)跌2.3%报283.4元，小米(01810.HK)跌1.4%报25.2元，美团(03690.HK)跌3.7%报322.8元，京东(09618.HK)跌7.5%报335元，网易(09999.HK)跌5.1%报137.1元。手机股舜宇(02382.HK)亦低开5.6%报150元，电动车生产商比亚迪(01211.HK)跌3.7%报188.7元。
金融股高开，汇控(00005.HK)高开7.2%报37.35元，渣打(02888.HK)升12%报42.55元，恒生(00011.HK)升4.6%报132.2元，友邦(01299.HK)升5.7%报87元，港交所(00388.HK)高开0.6%报390元。内银股建行(00939.HK)及工行(01398.HK)各高开1.9%，招行(03968.HK)高开3.4%。内险股中国平安(02318.HK)及国寿(02628.HK)各高开2.5%及2.8%。
较受疫情影响的濠赌股急涨，银娱(00027.HK)、永利澳门(01128.HK)及金沙中国(01928.HK)各高开10.5%、10%及9.7%，新濠国际(00200.HK)、澳博(00880.HK)及美高梅中国(02282.HK)各高开5.5%至7.1%。航空股方面，国泰(00293.HK)高开14.9%，东航(00670.HK)、国航(00753.HK)及南航(01055.HK)各高开9%至11.8%。中银航空租赁(02588.HK)急弹14%。
三桶油中石化(00386.HK)、中石油(00857.HK)及中海油(00883.HK)各高开6%至8.4%。
辉瑞及BioNTech新冠疫苗取得突破，合作夥伴复星医药(02196.HK)股价高开15%报37.6元，复星国际(00656.HK)亦扬4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
